Comparison of Adherence and Persistence Associated with First-Line Disease-Modifying Therapies among Patients with Multiple Sclerosis

被引：0
|
作者：
Halpern, Rachel
Agarwal, Sonalee
Borton, Leigh A.
Babic, Tomislav
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A547 / A548
页数：2
相关论文
共 50 条
  • [21] Impact of adherence to disease-modifying therapies on employment among veterans with multiple sclerosis
    Rabadi, Meheroz H.
    Just, Kimberly
    Xu, Chao
    DISABILITY AND REHABILITATION, 2022, 44 (16) : 4415 - 4420
  • [22] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    Qian Cai
    Sonalee Agarwal
    Judith J. Stephenson
    Siddhesh Kamat
    Advances in Therapy, 2011, 28 : 51 - 61
  • [23] Adherence to disease-modifying therapies among patients with multiple sclerosis in Bulgaria - A real world study
    Seitaridou, Yoana
    Chamova, Teodora
    Kamusheva, Maria
    PHARMACIA, 2024, 71 : 1 - 7
  • [24] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Tan, Hiangkiat
    Cai, Qian
    Agarwal, Sonalee
    Stephenson, Judith J.
    Kamat, Siddhesh
    ADVANCES IN THERAPY, 2011, 28 (01) : 51 - 61
  • [25] Effects of first-line and second-line disease-modifying therapies on cognitive function in persons with multiple sclerosis
    Ozakbas, Serkan
    Yigit, Pinar
    Sagici, Ozge
    Ozdogar, Asiye Tuba
    Abasiyanik, Zuhal
    Kahraman, Turhan
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (07) : 1052 - 1053
  • [26] PERSISTENCE TO ORAL AND INJECTABLE MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPIES
    Galaznik, A.
    Rusli, E.
    Lempernesse, B.
    Shilnikova, A.
    Ransom, J.
    Berger, M.
    VALUE IN HEALTH, 2019, 22 : S287 - S287
  • [27] Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
    Melesse, Dessalegn Y.
    Marrie, Ruth Ann
    Blanchard, James F.
    Yu, Bo Nancy
    Evans, Charity
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1093 - 1101
  • [28] Adherence to subcutaneous first-line disease modifying therapy in multiple sclerosis
    Oprea, Simona
    Negres, Simona
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 280 - 280
  • [29] Fostering adherence to injectable disease-modifying therapies in multiple sclerosis
    Lugaresi, Alessandra
    Rottoli, Maria Rosa
    Patti, Francesco
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (09) : 1029 - 1042
  • [30] Adherence to Multiple Sclerosis Disease-Modifying Therapies in Ontario is Low
    Wong, Janice
    Gomes, Tara
    Mamdani, Muhammad
    Manno, Michael
    O'Connor, Paul W.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2011, 38 (03) : 429 - 433
12345